1. ICH S7A safety pharmacology studies for human pharmaceuticals, implemented by MHLW, CPMP, FDA;Anon;Federal Register,2001
2. Title 21 Code of Federal Regulations (21 CFR Part 11) Electronic Records; Electronic Signatures;Anon,2003
3. Anon. (2004). ICH S7B Note for guidance on safety pharmacology studies for assessing the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. Step 2 Revised, 10 June 2004. CPMP/ICH/423/02.
4. Origins, practices and future of safety pharmacology;Bass;Journal of Pharmacological and Toxicological Methods,2004